FDA clears tiratricol for MCT8 deficiency, lowering dangerous T3 and outlining dosing, lab testing, and pharmacy access.
|Videos|May 24, 2017
How Can Independent Specialty Pharmacies Best Manage DIR Fees?
Cheryl Allen, vice president of Industry Relations at Diplomat, discusses the impact of direct and indirect remuneration fees on specialty pharmacy.
Advertisement
Cheryl Allen, vice president of Industry Relations at Diplomat, discusses the impact of direct and indirect remuneration fees on specialty pharmacy.
Advertisement
Related to this article
AI-driven coding fuels specialty EHRs and telehealth tools, making ePrescribing faster, tailored, and affordable while shifting focus to workflow and compliance.
The once-daily tablet is the third approved treatment for fibrodysplasia ossificans progressiva (FOP), with CYP3A4 and metformin interaction guidance.
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Tiratricol, First Treatment for MCT8 Deficiency
2
Pharmacists Can Close CKD Medication Adherence Gaps, PHTI Says
3
FDA Approves Tavapadon, First D1/D5 Agonist for Parkinson Disease
4
Expert Q&A: Researcher Urges Autonomic Assessment for Patients With Long COVID
5